These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Public funding of US syringe exchange programs. Des Jarlais DC, McKnight C, Milliken J. J Urban Health; 2004 Mar; 81(1):118-21. PubMed ID: 15047790 [Abstract] [Full Text] [Related]
23. Syringe-exchange programs in the United States: where are we now? Paone D, Des Jarlais D, Clark J, Shi Q. AIDS Public Policy J; 1996 Mar; 11(3):144-7. PubMed ID: 10915246 [No Abstract] [Full Text] [Related]
24. Measuring effectiveness of needle and syringe exchange programs for prevention of HIV among injecting drug users: Response to Amundsen. Maher L, Iversen J, Kaldor J. Addiction; 2006 Dec; 101(12):1834-6. PubMed ID: 17156184 [No Abstract] [Full Text] [Related]
38. [Risk reduction and intravenous drug use abstinence in patients with HIV infection. The SEROCO group]. Meyer L, Wade A, Persoz A, Boué F, Dellamonica P, Caroli-Bosc C, Carré N. Rev Epidemiol Sante Publique; 1998 Feb; 46(1):34-9. PubMed ID: 9533232 [Abstract] [Full Text] [Related]
40. Factors associated with buying and selling syringes among injection drug users in a setting of one of North America's largest syringe exchange programs. Kuyper LM, Kerr T, Li K, Hogg RS, Tyndall MW, Montaner JS, Wood E. Subst Use Misuse; 2006 Feb; 41(6-7):883-99. PubMed ID: 16809177 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]